Infection with Helicobacter pylori Strains Possessing cagA Is Associated with an Increased Risk of Developing Adenocarcinoma of the Stomach

Cancer Research

Volumn 55, Issue 10, 1995, Pages 2111-2115

  Blaser, Martin J ^a,b   Perez Perez, Guillermo I ^a   Kleanthous, Harry ^c   Cover, Timothy L ^a,b   Peek, Richard M ^a   Chyou, P H ^d   Stemmermann, Grant N ^d   Nomura, Abraham ^d  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Acambis   (United States)

^d Japan Hawaii Cancer Study ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER STAGING; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PATIENT SELECTION; PEPTIC ULCER; PHLEBOTOMY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL ANALYSIS; STOMACH ADENOCARCINOMA; STOMACH BIOPSY; STOMACH CANCER;

ADENOCARCINOMA; CASE-CONTROL STUDIES; GENES, BACTERIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMAN; IMMUNOGLOBULIN G; MALE; ODDS RATIO; STOMACH NEOPLASMS; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0029043658     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Blaser, M. J., and Parsonnet, J. Parasitism by the “slow” bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J. Clin. Invest., 94: 4–8, 1994.
2. Correa, P. Is gastric carcinoma an infectious disease? N. Engl. J. Med., 325: 1170–1171, 1991.
3. Talley, N. J., Zinsmeister, A. R., Dimagno, E. P., Weaver, A., Carpenter, H. A., Péréz-Péréz, G. I., and Blaser, M. J. Gastric adenocarcinoma and Helicobacter pylori infection. J. Natl. Cancer Inst., 83: 1734–1739, 1991.
4. Parsonnet, J., Friedman, G. D., Vandersteen, D. P., Chang, Y., Vogelman, J. H., Orentreich, N., and Sibley, R. K. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med., 325: 1127–1131, 1991.
5. Nomura, A., Stemmermann, G. N., Chyou P., Kato, I., Péréz-Péréz, G. I., and Blaser, M. J. Helicobacter pylori infection and gastric carcinoma in a population of Japanese-Americans in Hawaii. N. Engl. J. Med., 325: 1132–1136, 1991.
6. Forman, D., Sitas, F., Newell, D. G., Stacey, A. R., Boreham, J., Peto, R., Campbell, T. C., Li, J., and Chen, J. Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China. Int. J. Cancer, 46: 608–611, 1990.
7. EUROGAST Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet, 341: 1359–1362, 1993.
8. Asaka, M., Kimura, T., Kato, M., Kudo, M., Miki, K., Ogoshi, K., Kato, T., Tatsuta, M., and Graham, D. Y. Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer (Phila.), 73: 2691–2694, 1994.
9. Sipponen, P., and Hyvarinen, H. Role of Helicobacter pylori in the pathogenesis of gastritis, peptic ulcer and gastric cancer. Scand. J. Gastroenterol., 196 (Suppl): S3-S6, 1993.
10. Forman D., Newell, D. G., Fullerton F., Yarnell, J. W., Stacey, A. R., Wald, N., and Sitas, F. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br. Med. J., 302:1302–1305, 1991.
11. Correa, P. Human gastric carcinogenesis: a multistep and multifactorial process– First American Cancer Society Award lecture on cancer epidemiology and prevention. Cancer Res., 52: 6735–6740, 1992.
12. Taylor, D. N., and Blaser, M. J. The epidemiology of Helicobacter pylori infections. Epidemiol. Rev., 13: 42–59, 1991.
13. Akopyanz, N., Bukanov, N. O., Westblom, T. U., Kresovich, S., and Berg, D. E. DNA diversity among clinical isolates of Helicobacter-pylori detected by PCR-based RAPD fingerprinting. Nucleic Acids Res., 20: 5137–5142, 1992.
14. Fujimoto, S., Marshall, B., and Blaser, M. J. PCR-based restriction fragment length polymorphism typing of Helicobacter pylori. J. Clin. Microbiol., 32: 331–334, 1994.
15. Prewett, E. J., Bickley, J., Owen, R. J., and Pounder, R. E. DNA patterns of Helicobacter pylori isolated from gastric antrum, body, and duodenum. Gastroenterology, 102: 829–833, 1992.
16. Tummuru, M. K. R., Cover, T. L., and Blaser, M. J. Cloning and expression of a high molecular weight major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect. Immunol., 61: 1799–1809, 1993.
17. Covacci, A., Censini, S., Bugnoli, M., Petracca, R., Burroni, D., Macchia, G., Massone, A., Papini, E., Xiang, Z., Figura, N., et al Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc. Natl. Acad. Sci. USA, 90: 5791–5795, 1993.
18. Crabtree, J. E. Taylor, J. D., Wyatt, J. I., Heatly, R. V., Shallcross, T. M., Tompkins, D. S., and Rathbone, B. J. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet, 338: 332–335, 1991.
19. Peek, R. M., Miller, G. G., Tham, K. T., Péréz-Péréz, G. I., Cover, T. L., Dunn, D., and Blaser, M. J. Detection of cagA expression in vivo and demonstration of preferential cytokine expression by cagA+ H. pylori strains in gastric mucosa. Am. J. Gastroenterol., 89: 1344, 1994.
20. Cover, T. L., Dooley, C. P., and Blaser, M. J. Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuoliz-ing cytotoxin activity. Infect. Immunol., 58: 605–610, 1990.
21. Cover, T. L., Glupczynski, Y., Lage, A. P., Burette, A., Tummuru, M. K. R., Perez-Perez, G. I., and Blaser, M. J. Serologic detection of infection with cagA Helicobacter pylori strains. J. Clin. Microbiol., in press, 1995.
22. Dooley, C. P., Fitzgibbons, P. L., Cohen, H., Appleman, M. D., Péréz-Perez, G. I., and Blaser, M. J. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N. Engl. J. Med., 321: 1562–1566, 1989.
23. Cover, T. L., Cao, P., Murthy, U. K., Sipple, M. S., and Blaser, M. J. Serum neutralizing antibody response to the vacuolating cytotoxin of Helicobacter pylori. J. Clin. Invest., 90: 913–918, 1992.
24. Peek, R. M., Miller, G. G., Tham, K. T., Péréz-Péréz, G. I., Cover, T. L., Atherton, J. C., Dunn, D. G., and Blaser, M. J. Detection of Helicobacter pylori gene expression in human gastric mucosa. J. Clin. Microbiol., 33: 28–32, 1995.
25. Péréz-Péréz, G. I., Dworlrin, B. M., Chodos, J. E., and Blaser, M. J. Campylobacter pylori antibodies in humans. Ann. Int. Med., 109: 11–17, 1988.
26. Studier, F. W., and Moffatt, B. A. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J. Mol. Biol., 189: 113–130, 1986.
27. Baier, G., Baier-Bitterlich, G., Couture, C., Telford, D., Giampa, L., and Altman, A. An efficient expression, purification and immunodetection system for recombinant gene products. Biotechniques, 17: 94–99, 1994.
28. Parsonnet J., Blaser, M. J., Péréz-Péréz, G. I., Hargrett-Bean, N., and Tauxe, R. V. Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology, 102: 41–46, 1992.
29. Breslow, N. E., and Day, N. E. Statistical methods in cancer research. Vol. 1, pp. 191–246. Lyon, France: International Agency for Research on Cancer, 1980.
30. Harrell, F. E., Jr. The PHGLM procedure. In: S. P. Joyner (ed.), SUGI Supplemental Library User's Guide, pp. 267–294. Cary, NC: SAS Institute, 1983.
31. Walter S. Calculation of attributable risks from epidemiological data. Int. J. Epidemiol., 7: 175–182, 1978.
32. Lusted, L. B. Decision-making studies in patient management. N. Engl. J. Med., 284: 416–424, 1971.
33. Taylor, N. S., Fox, J. G., Akopyants, N. S., Berg, D. E., Thompson, N., Shames, B., Correa, P., Fontham, H., and Janney, F. Long-term colonization with single and multiple strains of Helicobacter pylori assessed by DNA fingerprinting. J. Clin. Microbiol., 33: 918–923, 1995.
34. Worth, R. M., and Kagan A. Ascertainment of men of Japanese ancestry in Hawaii through World War II selective service registration. J. Chronic Dis., 23: 389–397, 1970.
35. Crabtree, J. E., Wyatt, J. I., Sobala, G. M., Miller, G., Tompkins, D. S., Primrose, J. N., and Morgan, A. G. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut, 34: 1339–1343, 1993.
36. Crabtree, J. E., Wyatt, J. I., Trejdosiewicz, L. K., Peichl, P., Nichols, P. H., Ramsay, N., Primrose, J. N., and Lindley, I. J. D. Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J. Clin. Pathol., 47: 61–66, 1994.
37. Hirai, M., Azuma, T., Ito, S., Kato, T., Kohli, Y., and Fujiki, N. High prevalence of neutralizing activity to Helicobacter pylori cytotoxin in serum of gastric-carcinoma patients. Int. J. Cancer, 56: 56–60, 1994.
38. Sipponen, P., Riihela, M., Hyvarinen, H., and Seppala, K. Chronic non-atrophic “superficial” gastritis raises the risk of gastric cancer. Scand. J. Gastroenterol., 29: 336–340, 1994.
39. Sipponen, P. Gastric cancer: a long-term consequence of Helicobacter pylori infection? Scand. J. Gastroenterol., 29: 24–27, 1994.